Table 2:

Patient characteristics, VIRAGE study

CharacteristicsValues
Mean age (yr) (SD)63.0 (13.1)
Sex, female (No.) (%)37 (40.7)
Mean glycemia (mmol/L) (±SD)7.0 (2.5)
Intravenous fibrinolytic treatment (No.) (%)42 (46.2)
Median NIHSS score at presentation (Q1–Q3)11 (6–17)
mRS score at TP3 (Q1–Q3)2 (1–3)
    mRS >1, (No.) (%)/mRS ≤1 (No.) (%)54 (59.3)/36 (39.6)
    mRS >2, (No.) (%)/mRS ≤2 (No.) (%)32 (35.2)/58 (63.7)